What are the possible reasons why my condition has not been relieved after taking Avonib for three years?

The condition has not been relieved after three years of taking Ivosidenib (Ivosidenib), which may involve multiple reasons. The following is an analysis from the perspectives of drug indications, individual differences, drug resistance mechanisms and treatment strategies.

First, it is necessary to confirm whether the patient meets the indications for ivonib. Ivonib is a targeted drug targeting IDH1 mutations. It is mainly used to treat acute myeloid leukemia (AML) or cholangiocarcinoma carrying IDH1 mutations. If the patient does not carry the IDH1 mutation, or the condition itself is not within the scope of its approved indications, then it is understandable that no relief has been seen after taking the drug for three years, indicating that the treatment direction may be biased.

Secondly, individual differences may also lead to poor efficacy. Even if a patient clearly has an IDH1 mutation, different individuals have different absorption, metabolism, and response to drugs. Some patients may be less sensitive to ivonib or have comorbid diseases that affect drug efficacy. For example, liver and kidney dysfunction may affect drug metabolism, thereby reducing therapeutic efficacy.

Third, drug resistance may develop after long-term use of ivonib. Tumor cells may "escape" the inhibitory effect of ivonib by acquiring other gene mutations, activating bypass signaling pathways, or changing metabolic patterns, resulting in the drug's efficacy gradually weakening or even being completely ineffective.

Finally, a lack of adjustment in treatment regimens may also be a factor. If you have been using ivonib alone for three years without regular evaluation and adjustments based on efficacy, such as combining chemotherapy or switching to other targeted drugs, you may miss more effective treatment opportunities. It is recommended that patients communicate with their attending doctors to conduct genetic testing and comprehensive evaluation to find a more appropriate individualized treatment plan.

Reference link:https://www.tibsovo.com/